Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.740
+0.150 (3.27%)
Apr 13, 2026, 1:08 PM EDT - Market open
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $278.24 million as of April 13, 2026. Its market cap has increased by 31.32% in one year.
Market Cap
278.24M
Enterprise Value
160.03M
1-Year Change
31.32%
Ranking
Category
Stock Price
$4.74
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $278.24M, a decrease of -50.79%. That is a compound annual growth rate of -12.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 269.43M | -11.77% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 284.38M |
| Abeona Therapeutics | 280.11M |
| Anavex Life Sciences | 273.38M |
| NovaBridge Biosciences | 272.93M |
| Cellectis | 271.65M |
| Silence Therapeutics | 270.65M |
| Alector | 270.39M |
| Polaryx Therapeutics | 268.91M |